Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RTOG 9601: Radiation Therapy with or without Casodex in Recurrent Prostate Cancer
NCT00002874Phase 3Completed
- Sponsor
- NRG Oncology
- Start
- Feb 1998
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of bicalutamide in prostate cancer (PCa), sponsored by NRG Oncology. Started Feb 1998; status: completed.
02
Drugs
bicalutamide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00002874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002874.